Markets:

Overview

News

Currencies

International

Treasuries

Intelligent Bio Solutions Inc. - Common Stock (NQ:INBS)

0.5500 -0.0101 (-1.80%)

Streaming Delayed Price Updated: 11:08 AM EST, Dec 15, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Intelligent Bio Solutions Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Why Did INBS Stock Fall 17% Today? ↗

December 12, 2025

Intelligent Bio Solutions announced a 1-for-10 reverse stock split on Friday to regain listing compliance.

Via Stocktwits

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

Intelligent Bio Solutions Stock Rises On New Contract For Drug Testing Technology ↗

October 23, 2025

The new customer account represents one of INBS's most significant UK commercial deployments to date, the company said.

Via Stocktwits

Topics Cannabis

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 17, 2025

Via Benzinga

Which stocks are experiencing notable movement on Wednesday? ↗

September 17, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Wednesday's session: gap up and gap down stocks ↗

September 17, 2025

Let's delve into the US markets on Wednesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4 ↗

August 07, 2025

Intelligent Bio forecasts 16% revenue growth for Q4 2025 and strengthens FDA filing with new data as it expands global reach and system capabilities.

Via Benzinga

EXCLUSIVE: Intelligent Bio Solutions' New Data Confirms Ability To Detect Trace Sweat Volumes At Ultra-Micro Level ↗

July 23, 2025

Intelligent Bio strengthens its FDA 510(k) submission with new data, cybersecurity tests, and advanced fingerprint sweat analysis technology.

Via Benzinga

EXCLUSIVE: Intelligent Bio Targets Global Market With Distribution Pact For Sweat-Based Drug Detection Patch ↗

July 16, 2025

Intelligent Bio expands global reach with SMARTOX deal to distribute its sweat-based drug detection patch across markets outside the U.S. and Canada.

Via Benzinga

EXCLUSIVE: Intelligent Bio's Fingerprint Drug Testing Gains Momentum With New Australian Rollout ↗

June 18, 2025

Intelligent Bio Solutions expands into environmental services as Managed Waste Service rolls out its drug testing system across New South Wales sites.

Via Benzinga

Intelligent Bio Rises On Partnership With Smartox To Expand US Market Presence: Retail Hopes The Stock To Hit $2.6 ↗

June 11, 2025

Intelligent Bio is actively pursuing FDA clearance for its opiate test system for codeine, utilizing its fingerprint sweat-based testing technology.

Via Stocktwits

EXCLUSIVE: Intelligent Bio Solutions Expands US Forensic Market Presence, Seeks FDA Clearance For Fingerprint Drug Testing ↗

June 11, 2025

Intelligent Bio grows U.S. forensic market presence via SMARTOX, with 7,000+ tests run and FDA clearance underway for wider market entry.

Via Benzinga

EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91% ↗

May 13, 2025

Intelligent Bio Solutions reported a Q3 loss of 44 cents per share with a 20% revenue rise from Q2 and 91% year-over-year gross profit growth.

Via Benzinga

EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology ↗

March 26, 2025

Intelligent Bio Solutions (INBS) received a U.S. patent for its fingerprint drug screening technology, expanding its intellectual property portfolio.

Via Benzinga

Topics Intellectual Property

EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch ↗

March 25, 2025

Intelligent Bio Solutions awaits FDA clearance for its fingerprint drug test, aiming for a 2025 U.S. launch and expanding its presence in the multi-billion market.

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

February 20, 2025

The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

February 20, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

Which stocks are moving after the closing bell on Wednesday? ↗

February 19, 2025

The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

EXCLUSIVE: Intelligent Bio Solutions Expects To Record Increased Profitability In Q2 On Higher-Margin Sales ↗

February 06, 2025

Intelligent Bio Solutions reports rising sales and profit margins, driven by recurring revenue from cartridge sales and global expansion through key partnerships.

Via Benzinga

EXCLUSIVE: Intelligent Bio Solutions Partners With UK-Based Quantum TM For Fingerprint Drug Testing At 10 Sites ↗

January 29, 2025

Quantum Traffic Management adopts INBS' Intelligent Fingerprinting Drug Testing Solution to improve efficiency and safety, with plans to expand in US.

Via Benzinga

EXCLUSIVE: Intelligent Bio Solutions Partners With IVY Diagnostics, Seeks Expansion In Europe's $3.6 Billion Drug Screening Market ↗

January 28, 2025

Intelligent Bio Solutions collaborates with IVY Diagnostics to enhance drug screening adoption in Europe and the Middle East, targeting key regions.

Via Benzinga

Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher ↗

September 09, 2024

Via Benzinga

Nasdaq Surges Over 1%; US Wholesale Inventories Rise 0.2% In July ↗

September 09, 2024

Via Benzinga

What's Going On With Opiate Screening Tests-Focused Intelligent Bio Solutions Stock On Monday? ↗

September 09, 2024

Intelligent Bio Solutions stock surges with increased trading volume, driven by progress on its FDA 510(k) submission. The company, specializing in non-invasive testing, advances clinical trials and...

Via Benzinga

US Stocks Higher; Dow Surges Over 200 Points ↗

September 09, 2024

Via Benzinga

Topics Stocks

Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

September 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 16, 2024

Via Benzinga

INBS Stock Earnings: Intelligent Bio Solutions Beats EPS, Misses Revenue for Q3 2024 ↗

May 08, 2024

INBS stock results show that Intelligent Bio Solutions beat analyst estimates for earnings per share but missed on revenue for the third quarter of 2024.

Via InvestorPlace

Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth ↗

April 25, 2024

Intelligent Bio Solutions (Nasdaq: INBS) is a medical technology company developing and commercializing innovative, intelligent, rapid, noninvasive testing solutions.

Via Talk Markets

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.